Ghahestani Seyyed Mohammad*1,Sara Karimi 2,Mohammad Hamidi Madani3
*1: 1Children Medical Center Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran. Email: mgrosva@gmail.com.No:+989128491811
Address: Pediatric Urology Ward,Children Medical Centre Hospital ,Gharib St, Keshavarz Blvd,Tehran,Iran
2:Sara Karimi, Alborz University of Medical sciences. E mail:Sarakarimi1984@yahoo.com
No:+989133004032
3: Mohammad Hamidi Madani.Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences(SBMU). Email:m.hamidimadani70@gmail.com Phone No:+989393898696
Abstract:
In previous publications the role of kininogen system has been postulated. On those publications the possible role of Icatibant, Ecallantide and Aprotinin in treatment of SARS Cov-2 has been raised. In this paper we raise the hypothetical potential of Methylene Blue in treatment of SARS COV 2. This medication may abort effects of Bradykinin by inhibition of NO Synthase inhibitor and promote oxygen saturation while it is inexpensive and ubiquitously accessible. Clinical studies can not be over emphasized.